Anthony Goldstone built a transplant program. It started in a broom cupboard.
At age 28, he was a senior registrar in clinical and laboratory haematology at Addenbrooke’s Hospital in Cambridge. After earning his MRCPath at
At age 28, he was a senior registrar in clinical and laboratory haematology at Addenbrooke’s Hospital in Cambridge. After earning his MRCPath at
The study assessed the safety and outcomes of pemivibart in the oncology subset from the open-label, single-arm, immunocompromised Cohort A of the phase
The drug had earlier received the FDA’s breakthrough designation and orphan drug designation, making the application eligible for priority review. Efficacy was evaluated
As a first-line treatment for patients with marginal zone lymphoma, the combination of bendamustine with rituximab (BR) conferred no advantage in overall survival
This issue of SOHO Insider features an article on US patient representation in global trials, an interview with Dr. Naval Daver, and photos
The US Food and Drug Administration has granted accelerated approval to sonrotoclax, a BCL-2 inhibitor, for adults with relapsed or refractory mantle cell
SOHO invites delegates and attendees to submit an abstract for a poster or oral presentation during the Fourteenth Annual Meeting of the Society
In this interview from the AACR Annual Meeting 2026, Shuguang Leng, MBBS, PhD, an associate professor at the University of New Mexico Comprehensive
Meet Naval Daver, MD, a professor and director of the Leukemia Molecular Laboratory in the Department of Leukemia at the University of Texas
In this SOHO Insider podcast, host Megan Melody, MD, from Tampa General Hospital, spoke with Nirav Shah, MD, professor at the Medical College